Abstract
Malignant tumors of the epidermis are referred to as nonmelanoma skin cancer (NMSC). NMSC is considered the most common human malignancy and the incidence of SCC has increased noticeably over previous decades. There are a number of factors (acquired and genetics) that can play a key role in predisposition to SCC. The initial manifestation of SCC is known as actinic keratosis and between 1 and 10% of AK progress into invasive squamous cell carcinoma. The diagnosis of SCC, although easily made in typical cases, may sometimes be difficult. On this regard, dermatoscopic examination can play a central role to increase the specificity of the diagnosis of such lesions. A universally accepted staging system for risk stratification of cutaneous SCC is not yet available. The aim of the treatment of SCC can be stated simply as follows: to eliminate the disease, to secure the best functional and cosmetic results, and to avoid relapse. The treatment should take into consideration not only the SCC but also actinic keratosis from whom the SCC has originated. In this chapter, we go through epidemiological aspects, diagnosis, and treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- 5-FU:
-
5-fluorouracil
- AK:
-
Actinic keratosis
- ALA:
-
5-aminolevulinic acid
- AMM:
-
Melanotic melanoma
- BCC:
-
Basal cell carcinoma
- COX:
-
Cyclooxygenase
- EGFR:
-
Epidermal growth factor receptor
- NMSC:
-
Nonmelanoma skin cancer
- PDT:
-
Photodynamic therapy
- PpIX:
-
Protoporphyrin IX
- PUVA:
-
Photochemotherapy
- SCC:
-
Squamous cell carcinoma
- SK:
-
Seborrheic keratosis
References
Cranmer LD, Engelhardt C, Morgan SS. Treatment of unresectable and metastatic cutaneous squamous cell carcinoma. Oncologist. 2010;15(12):1320–8.
Green AC, Olsen CM. Cutaneous squamous cell carcinoma: an epidemiological update. Br J Dermatol. 2017;177(2):373–81.
Hoogendijk-van den Akker JM, Harden PN, Hoitsma AJ, Proby CM, Wolterbeek R, Bouwes. Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus. J Clin Oncol. 2013;31:1317–23.
Zalaudek I, Giacomel J, Argenziano G, HofmannWellenhof R, Micantonio T, Di Stefani A, Oliviero M, Rabinovitz H, Soyer HP, Peris K. Dermoscopy of facial nonpigmented actinic keratosis. Br J Dermatol. 2006;155(5):951–6.
Further Reading
Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975–83.
Aldabagh B, Angeles JG, Cardones AR, Arron ST. Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? Dermatol Surg. 2013;39:1–23.
Berman B, Amini S. Pharmacotherapy of actinic keratosis: an update. Expert Opin Pharmacother. 2012;13(13):1847–71.
Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis. 2005;26(10):1657–67.
Cantisani C, De Gado F, Ulrich M, Bottoni U, Richetta AG, Calvieri S. Actinic keratosis: review of the literature and new patents. Recent Pat Inflamm Allergy Drug Discov. 2013;7:168–75.
Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg. 2002;28:268–73.
De Giorgi V, Alfaioli B, Papi F, Janowska A, Grazzini M, Lotti T, Massi D. Dermoscopy in pigmented squamous cell carcinoma. J Cutan Med Surg. 2009;13(6):326–9.
DeConti RC. Chemotherapy of squamous cell carcinoma of the skin. Semin Oncol. 2012;39(2):145–9.
Dirschka T, Radny P, Dominicus R, et al. Study groups. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol. 2013;168(4):825–36.
Fargnoli MC, Kostaki D, Piccioni A, Micantonio T, Peris K. Dermoscopy in the diagnosis and management of non-melanoma skin cancers. Eur J Dermatol. 2012;22(4):456–63.
Flohil SC, van der Leest RJ, Dowlatshahi EA, Hofman A, de Vries E, Nijsten T. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam study. J Invest Dermatol. 2013;133:1971–8.
Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II Squamous cell carcinoma. Arch Dermatol. 1995;131:164–9.
Goldberg LH, Kaplan B, Vergilis-Kalner I, Landau J. Liquid nitrogen: temperature control in the treatment of actinic keratosis. Dermatol Surg. 2010;36(12):1956–61.
Gray DT, Suman VJ, Su WP, Clay RP, Harmsen WS, Roenigk RK. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol. 1997;133:735–40.
Grazzini M, Stanganelli I, Rossari S, Gori A, Oranges T, Longo AS, Lotti T, Bencini PL, De Giorgi V. Dermoscopy, confocal laser microscopy, and hitech evaluation of vascular skin lesions: diagnostic and therapeutic perspectives. Dermatol Ther. 2012;25(4):297–303.
Guidelines of care for cutaneous squamous cell carcinoma. Committee on guidelines of care, task force on cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1993;28:628–31.
Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol. 1992;26:467–84.
Khan MH, Alam M, Yoo S. Epidermal growth factor receptor inhibitors in the treatment of nonmelanoma skin cancers. Dermatol Surg. 2011;37(9):1199–209.
Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166:1069–80.
Martin GM, Stockfleth E. Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety. J Drugs Dermatol. 2012;11(5):600–8.
Minton TJ. Contemporary Mohs surgery applications. Curr Opin Otolaryngol Head Neck Surg. 2008;16:376–80.
Muellenhoff MW, Koo JY. Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology. J Dermatol Treat. 2012;23(4):290–304.
Pons M, Quintanilla M. Molecular biology of malignant melanoma and other cutaneous tumors. Clin Transl Oncol. 2006;8(7):466–74.
Ratushny V, Gober MD, Hick R, Ridky TW, Seykora JT. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest. 2012;122(2):464–72.
Rosendahl C, Cameron A, Argenziano G, Zalaudek I, Tschandl P, Kittler H. Dermoscopy of squamous cell carcinoma and keratoacanthoma. Arch Dermatol. 2012;148(12):1386–92.
Rudolph R, Zelac D. Squamous cell carcinoma of the skin. Plast Reconstr Surg. 2004;114:82–94.
Salasche S. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:4–7.
Schwartz RA. Keratoacanthoma. J Am Acad Dermatol. 1994;30:1–22.
Stern RS, PUVA follow-up study. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet a therapy: a 30-year prospective study. J Am Acad Dermatol. 2012;66(4):553–6.
Stough D, Bucko AD, Vamvakias G, Rafal ES, Davis SA. Fluorouracil cream 0.5% for actinic keratoses on multiple body sites: an 18-month open-label study. Cutis. 2010;85(5):267–73.
Strohal R, Kerl H, Schuster L. Treatment of actinic keratoses with 5% topical imiquimod: a multicenter prospective observational study from 93 Austrian office-based dermatologists. J Drugs Dermatol. 2012;11(5):574–8.
Terushkin V, Braga JC, Dusza SW, Scope A, Busam K, Marghoob AA, Gill M, Halpern AC. Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms. Dermatol Surg. 2010;36(10):1514–20.
Wehner MR, Shive ML, Chren MM, Han J, Qureshi AA, Linos E. Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis. BMJ. 2012;345:e5909.
Zalaudek I, Kreusch J, Giacomel J, Ferrara G, Catricalà C, Argenziano G. How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part II. Nonmelanocytic skin tumors. J Am Acad Dermatol. 2010;63(3):377–86.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Grazzini, M., De Giorgi, V. (2023). Squamous Cell Carcinoma. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_91
Download citation
DOI: https://doi.org/10.1007/978-3-031-15130-9_91
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15129-3
Online ISBN: 978-3-031-15130-9
eBook Packages: MedicineMedicine (R0)